The Top Analysis for Sonnet BioTherapeutics Holdings Inc (SONN)


The top analysis was written by Muhammad Shoaib titled Sonnet Biotherapeutics Holding Inc. | Sonn Stock Analysis

Is Sonnet BioTherapeutics Holdings Inc (SONN) a buy?

Based on 1 suggestion, Sonnet BioTherapeutics Holdings Inc(SONN) is recommended as a HOLD at $2.50.

Are These Ratings Good?

Based on 1 ratings, the average Return is -37.90%.
The community has not been successfully rating this stock.

Forecast for Sonnet BioTherapeutics Holdings Inc (SONN)

Based on the most recent price of $1.81,
the two year forecast for SONN is $1.90.
The four year forecast is $1.99
Forecast is based on the aggregate sentiment of users on the platform. The sentiment of top investors get a higher ranking when assessing the forecast.